ONCOLOGÍA

Publicaciones en 2021 /Publicaciones en 2020 /Publicaciones en 2019 / Publicaciones en 2018 / Publicaciones en 2017 / Publicaciones en 2016 / Publicaciones en 2015

Publicaciones en 2021

Valentí V, Jiménez-Fonseca P, Msaouel P, Salazar R, Carmona-Bayonas A. Fooled by randomness. The misleading effect of treatment crossover in randomized trials of therapies with marginal treatment benefit. Cancer Invest. 2021 Dec 17:1-7. doi: 10.1080/07357907.2021.2020281. PMID: 34919008

Flores-Funes D, Aguilar-Jiménez J, Martínez-Gálvez M, Ibáñez-Ibáñez MJ, Carrasco-González L, Gil-Izquierdo JI, Chaves-Benito MA, Ayala-De La Peña F, Nieto-Olivares A, Aguayo-Albasini JL. Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment. Surg Oncol. 2021 Sep;38:101629. doi: 10.1016/j.suronc.2021.101629. PMID: 34171793

Carmona-Bayonas A, Calderón C, Hernández R, Fernández Montes A, Castelo B, Ciria-Suarez L, Antoñanzas M, Rogado J, Pacheco-Barcia V, Asensio Martínez E, Ivars A, Ayala de la Peña F, Jimenez-Fonseca P. Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy. NPJ Breast Cancer. 2021 Jul 13;7(1):92. doi: 10.1038/s41523-021-00296-8. PMID: 34257315

Flores-Funes D, Aguilar-Jiménez J, Martínez-Gálvez M, Ibáñez-Ibáñez MJ, Carrasco-González L, Gil-Izquierdo JI, Chaves-Benito MA, Ayala-De La Peña F, Nieto-Olivares A, Aguayo-Albasini JL. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results. Surg Oncol. 2021 Sep;38:101636. doi: 10.1016/j.suronc.2021.101636. PMID: 34303211

Martín García A, Mitroi C, Mazón Ramos P, García Sanz R, Virizuela JA, Arenas M, Egocheaga Cabello I, Albert D, Anguita Sánchez M, Arrarte Esteban VI, Ayala de la Peña F, Bonanand Lozano C, Castro A, Castro Fernández A, Córdoba R, Cosín-Sales J, Chaparro-Muñoz M, Dalmau R, Drak Hernández Y, Deiros Bronte L, Díez-Villanueva P, Escobar Cervantes C, Fernández Redondo C, García Rodríguez E, Lozano T, Marco Vera P, Martínez Monzonis A, Mesa D, Oristrell G, Palma Gámiz JL, Pedreira M, Reinoso-Barbero L, Rodríguez I, Serrano Antolín JM, Toral B, Torres Royo L, Velasco Del Castillo S, Vicente-Herrero T, Zatarain-Nicolás E, Tamargo J, López Fernández T. Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC. Rev Esp Cardiol (Engl Ed). 2021 May;74(5):438-448. doi: 10.1016/j.rec.2020.11.020. PMID: 33712348

Ayala de la Peña F, Ortiz-Muñoz B, Quintanar-Verdúguez T, Santotoribio JD, de la Cruz S, Trapé-Pujol J, Galve-Calvo E, Augé-Fradera JM, García-Gómez J, González-Hernández Á. Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer. Clin Transl Oncol. 2021 Jul;23(7):1272-1280. doi: 10.1007/s12094-020-02529-x. PMID: 33550504

Muñoz-Langa J, Jimenez-Fonseca P, Carmona-Bayonas A, de Castro EM, Pérez-Segura P, Cánovas MS, Gomez D, Moran LO, de Tejada MBG, Seguí E, López GB, Adrián SG, Campos MC, Olmos VP, Portero BO, Moyano MS, Crespo JAS, Sánchez LT, Rebollo MA, Rivas PO, Altozano JP, Lescure ÁR, Muñoz-Martín A. Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology). Clin Transl Oncol. 2021 Apr;23(4):799-811. doi: 10.1007/s12094-020-02472-x. PMID: 32789772

Viúdez A, Crespo G, Gómez Dorronsoro ML, Arozarena I, Marín-Méndez JJ, Custodio A, Benavent M, Goñi S, García-Paredes B, Hernando J, Durantez M, Alonso V, Riesco MDC, López C, Jiménez-Fonseca P, San Vicente BL, González-Borja I, Sevilla I, Hernández-Garcia I, Carmona-Bayonas A, Capdevila J, Pérez-Sanz J, García-Carbonero R, Pérez-Ricarte L, Llanos M, Vera R, De Jesús Acosta A. Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus. Pancreatology. 2021 Jan;21(1):215-223. doi: 10.1016/j.pan.2020.12.009. PMID: 33358592

Gomez D, Calderón C, Carmona-Bayonas A, Cacho Lavin D, Muñoz MM, Martinez Cabañez R, Jimenez-Fonseca P. Impact of adjuvant therapy toxicity on quality of life and emotional symptoms in patients with colon cancer: a latent class analysis. Clin Transl Oncol. 2021 Mar;23(3):657-662. doi: 10.1007/s12094-020-02454-z. PMID: 32676895

Valenti V, Carmona-Bayonas A, Jimenez-Fonseca P, Salazar R. Olaratumab-induced Biomarker Modulation in Sarcomas. Mol Cancer Ther. 2021 Oct;20(10):2093. doi: 10.1158/1535-7163.MCT-21-0413. PMID: 34607901

Calderon C, Gomez D, Carmona-Bayonas A, Hernandez R, Ghanem I, Gil Raga M, Ostios Garcia L, Garcia Carrasco M, Lopez de Ceballos MH, Ferreira E, Jimenez-Fonseca P. Social support, coping strategies and sociodemographic factors in women with breast cancer. Clin Transl Oncol. 2021 Sep;23(9):1955-1960. doi: 10.1007/s12094-021-02592-y. PMID: 33840046

Peñas-Martínez J, Luengo-Gil G, Espín S, Bohdan N, Ortega-Sabater C, Ródenas MC, Zaragoza-Huesca D, López-Andreo MJ, Plasencia C, Vicente V, Carmona-Bayonas A, Martínez-Martínez I. Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells. Biomedicines. 2021 May 7;9(5):523. doi: 10.3390/biomedicines9050523. PMID: 34067120

Fernández Montes A, Carmona-Bayonas A, Jimenez-Fonseca P, Vázquez Rivera F, Martinez Lago N, Covela Rúa M, Cousillas Castiñeiras A, Gonzalez Villarroel P, De la Cámara Gómez J, Méndez JCM, Carriles Fernández C, Sanchez Cánovas M, Garcia García T. Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data. Sci Rep. 2021 Jul 12;11(1):14321. doi: 10.1038/s41598-021-93732-5. PMID: 34253805

Jimenez-Fonseca P, Carmona-Bayonas A, Martínez de Castro E, Custodio A, Pericay Pijaume C, Hernandez R, Aguado G, Castro Unanua N, Cano JM, López F, Garrido M, Fernández Montes A, Visa L, Sánchez Cánovas M, Limón ML, Martínez Lago N, Pimentel P, Hurtado A, Azkárate A, Longo F, Diez M, Arias-Martinez A, Sauri T, Martín Carnicero A, Mangas M, Martín Richard M, Granja M, Ramchandani A, Hernández Pérez C, Cerdá P, Gil-Negrete A, Calvo M, Vidal Tocino R, Gallego J. External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit? Gastric Cancer. 2021 Mar;24(2):445-456. doi: 10.1007/s10120-020-01116-x. PMID: 32970266

Gomez D, Jimenez-Fonseca P, Fernández AM, Castellanos PC, Arbizu MV, Cabañes RM, Estellés DL, Ferreira E, Del Rio J, García TG, Carmona-Bayonas A, Calderon C. Impact of Obesity on Quality of Life, Psychological Distress, and Coping on Patients with Colon Cancer. Oncologist. 2021 May;26(5):e874-e882. doi: 10.1002/onco.13687. PMID: 33492756

Alvarez-Manceñido F, Jimenez-Fonseca P, Carmona-Bayonas A, Arrazubi V, Hernandez R, Cano JM, Custodio A, Pericay Pijaume C, Aguado G, Martínez Lago N, Sánchez Cánovas M, Cacho Lavin D, Visa L, Martinez-Torron A, Arias-Martinez A, López F, Limón ML, Vidal Tocino R, Fernández Montes A, Alsina M, Pimentel P, Reguera P, Martín Carnicero A, Ramchandani A, Granja M, Azkarate A, Martín Richard M, Serra O, Hernández Pérez C, Hurtado A, Gil-Negrete A, Sauri T, Morales Del Burgo P, Gallego J. Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry. Gastric Cancer. 2021 Jul;24(4):926-936. doi: 10.1007/s10120-021-01169-6. PMID: 33651195

García-Alfonso P, Muñoz A, Jiménez-Castro J, Jiménez-Fonseca P, Pericay C, Longo-Muñoz F, Reyna-Fortes C, Argilés-Martínez G, González-Astorga B, Gómez-Reina MJ, Ruiz-Casado A, Rodríguez-Salas N, López-López R, Carmona-Bayonas A, Conde-Herrero V, Aranda E, On Behalf Of The Ros Study Group. Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study. Cancers (Basel). 2021 Sep 8;13(18):4514. doi: 10.3390/cancers13184514. PMID: 34572740

Calderon C, Jiménez-Fonseca P, Hernández R, Muñoz MDM, Martínez de Castro E, Higuera O, Ghanem I, Castelo B, Rogado J, Carmona-Bayonas A. Prospective Study Comparing Clinicians' and Cancer Patients' Estimates of Risk of Relapse and Toxicity with Adjuvant Chemotherapy Cancer Invest. 2021 Sep;39(8):589-596. doi: 10.1080/07357907.2021.1948561. PMID: 34182858

Custodio A, Jimenez-Fonseca P, Carmona-Bayonas A, Gomez MJ, Del Olmo-García MI, Lorenzo I, Díaz JÁ, Canal N, De la Cruz G, Villabona C. Use of healthcare REsources and associated COsts in controlled versus uncontrolled carcinoid SYndrome in patients with neuroendocrine tumours: the RECOSY study. Clin Transl Oncol. 2021 Oct;23(10):2046-2056. doi: 10.1007/s12094-021-02608-7. PMID: 34109562

Carmona-Bayonas A, Valentí V, Jiménez-Fonseca P, Salazar R. SUNRISE-DI study. The daily sunrise is easier to predict than the benefit of adjuvant treatment in colon cancer. ESMO Open. 2021 Aug;6(4):100205. doi: 10.1016/j.esmoop.2021.100205. PMID: 34242967.

Jimenez-Fonseca P, Carmona-Bayonas A, Martinez-Torron A, Alsina M, Custodio A, Serra O, Cacho Lavin D, Limón ML, Sauri T, López F, Visa L, Granja M, Martínez Lago N, Arrazubi V, Vidal Tocino R, Hernandez R, Aguado G, Cano JM, Martín Carnicero A, Mangas M, Pimentel P, Fernández Montes A, Macias Declara I, Longo F, Ramchandani A, Martín Richard M, Hurtado A, Azkarate A, Hernández Pérez C, Serrano R, Gallego J; AGAMENON-SEOM study group. External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry. Ther Adv Med Oncol. 2021 Jun 17;13:17588359211019672. doi: 10.1177/17588359211019672. PMID: 34211587

Jiménez-Fonseca P, Salazar R, Valentí V, Carmona-Bayonas A, Agnelli G. Learning in times of stress: Lessons from COVID-19 that will last throughout this century. Eur J Intern Med. 2021 Nov 12:S0953-6205(21)00377-0. doi: 10.1016/j.ejim.2021.11.002.PMID: 34801401

Carmona-Bayonas A, Jiménez-Fonseca P, Gallego J, Msaouel P. Causal Considerations Can Inform the Interpretation of Surprising Associations in Medical Registries. Cancer Invest. 2021 Nov 25:1-13. doi: 10.1080/07357907.2021.1999971. PMID: 34709109

Carmona-Bayonas A, Jimenez-Fonseca P, Valenti V, Salazar R. Bayesian interpretation of the ESMO guideline for localized colorectal cancer: a better IDEA. Ann Oncol. 2021 Jul;32(7):938-939. doi: 10.1016/j.annonc.2021.03.003. PMID: 33741443

Publicaciones en 2020

Peters S, Danson S, Hasan B, Dafni U, Reinmuth N, Majem M, Tournoy KG, Mark MT, Pless M, Cobo M, Rodriguez-Abreu D, Falchero L, Moran T, Ortega Granados AL, Monnet I, Mohorcic K, Sureda BM, Betticher D, Demedts I, Macias JA, Cuffe S, Luciani A, Sanchez JG, Curioni-Fontecedro A, Gautschi O, Price G, Coate L, von Moos R, Zielinski C, Provencio M, Menis J, Ruepp B, Pochesci A, Roschitzki-Voser H, Besse B, Rabaglio M, O'Brien MER, Stahel RA. A randomised open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC - the ETOP and EORTC SPLENDOUR trial. J Thorac Oncol. 2020 Jun 18:S1556-0864(20)30481-0. doi: 10.1016/j.jtho.2020.06.011. PMID: 32565388

Carmona-Bayonas A, Jimenez-Fonseca P, Sánchez Arraez Á, Álvarez Manceñido F, Castañón E. Does active smoking worsen Covid-19? Eur J Intern Med. 2020 Jul;77:129-131. doi: 10.1016/j.ejim.2020.05.038. Epub 2020 May 28. PMID: 32507518

González-Del-Alba A, Arranz JÁ, Bellmunt J, Maroto JP, Fernández-Calvo O, Valderrama BP, González-Billalabeitia E, Méndez-Vidal MJ, Cassinello J, Romero-Laorden N, Climent MÁ, Puente J, Peláez I, Lázaro-Quintela M, Gallardo E, Suárez C. Latest progress in molecular biology and treatment in genitourinary tumours. Clin Transl Oncol. 2020 May 21. doi: 10.1007/s12094-020-02373-z. PMID: 32440915

Carmona-Bayonas A, Gómez D, Martínez de Castro E, Pérez Segura P, Muñoz Langa J, Jimenez-Fonseca P, Sánchez Cánovas M, Ortega Moran L, García Escobar I, Rupérez Blanco AB, Fernández Pérez I, Martínez de Prado P, Porta I Balanyà R, Quintanar Verduguez T, Rodríguez-Lescure Á, Muñoz A. A snapshot of cancer-associated thromboembolic disease in 2018-2019: First data from the TESEO prospective registry. Eur J Intern Med. 2020 May 29:S0953-6205(20)30224-7. doi: 10.1016/j.ejim.2020.05.031. Online ahead of print. PMID: 32482596

Carmona-Bayonas A, Jimenez-Fonseca P, Castañón E. A Trial of Lopinavir-Ritonavir in Covid-19. N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. PMID: 32369285

Martín-Richard M, Carmona-Bayonas A, Custodio AB, Gallego J, Jiménez-Fonseca P, Reina JJ, Richart P, Rivera F, Alsina M, Sastre J. SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019). Clin Transl Oncol. 2020 Feb;22(2):236-244. PMID: 31989475

Muñoz Martín AJ, Jiménez-Fonseca P, Carmona-Bayonas A, Martínez de Castro E, Muñoz Langa J, Pérez Segura P, Rodríguez Lescure A, Vera García R; Cancer and Thrombosis Section, Spanish Society of Medical Oncology (SEOM). TESEO, cancer-associated thrombosis registry from the Spanish Society of Medical Oncology (SEOM). Clin Transl Oncol. 2020 Aug;22(8):1423-1424. PMID: 31873915

Tran B, Ruiz-Morales JM, Gonzalez-Billalabeitia E, Patrikidou A, Amir E, Seidel C, Bokemeyer C, Fankhauser C, Hermanns T, Rumyantsev A, Tryakin A, Brito M, Fléchon A, Kwan EM, Cheng T, Castellano D, Garcia Del Muro X, Hamid AA, Ottaviano M, Palmieri G, Kitson R, Reid A, Heng DYC, Bedard PL. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3). Cancer Med. 2020 Jan;9(1):116-124. PMID: 31715650

Viúdez A, Carmona-Bayonas A, Gallego J, Lacalle A, Hernández R, Cano JM, Macías I, Custodio A, Martínez de Castro E, Sánchez A, Iglesia L, Reguera P, Visa L, Azkarate A, Sánchez-Cánovas M, Mangas M, Limón ML, Martínez-Torrón A, Asensio E, Ramchandani A, Martín-Carnicero A, Hurtado A, Cerdà P, Garrido M, Sánchez-Bayonas R, Serrano R, Jiménez-Fonseca P; AGAMENON Study Group. Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry. Clin Transl Oncol. 2020 May;22(5):734-750. PMID: 31385226

Ghanem I, Castelo B, Jimenez-Fonseca P, Carmona-Bayonas A, Higuera O, Beato C, García T, Hernández R, Calderon C. Coping strategies and depressive symptoms in cancer patients. Clin Transl Oncol. 2020 Mar;22(3):330-336. PMID: 31077086

Fankhauser CD, Tran B, Pedregal M, Ruiz-Morales JM, Gonzalez-Billalabeitia E, Patrikidou A, Amir E, Seidel C, Bokemeyer C, Hermanns T, Rumyantsev A, Tryakin A, Brito M, Fléchon A, Kwan EM, Cheng T, Castellano D, Del Muro XG, Hamid AA, Ottaviano M, Palmieri G, Kitson R, Reid A, Heng DYC, Bedard PL, Sweeney CJ, Connors JM.A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy. Eur Urol Focus. 2020 Oct 5:S2405-4569(20)30280-7. doi: 10.1016/j.euf.2020.09.017. PMID: 33032968

Puente J, Anido U, Climent MÁ, Gonzalez-Billalabeitia E, Lainez N, Lambea J, Maroto JP, Mendez-Vidal MJ, Montesa Á, Rodriguez A, Zambrana C, González-Del-Alba A. Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE. Ther Adv Med Oncol. 2020 May 27;12:1758835920920067. doi: 10.1177/1758835920920067. PMID: 33014145

Jimenez-Fonseca P, Carmona-Bayonas A, Martínez de Castro E, Custodio A, Pericay Pijaume C, Hernandez R, Aguado G, Castro Unanua N, Cano JM, López F, Garrido M, Fernández Montes A, Visa L, Sánchez Cánovas M, Limón ML, Martínez Lago N, Pimentel P, Hurtado A, Azkárate A, Longo F, Diez M, Arias-Martinez A, Sauri T, Martín Carnicero A, Mangas M, Martín Richard M, Granja M, Ramchandani A, Hernández Pérez C, Cerdá P, Gil-Negrete A, Calvo M, Vidal Tocino R, Gallego J. External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit? Gastric Cancer. 2020 Sep 24. doi: 10.1007/s10120-020-01116-x. PMID: 32970266

Gálvez MM, Jiménez JA, Gil Izquierdo JI, Alcaraz AC, Benito AC, González LC, Ortiz GP, Funes DF, Aguayo Albasini JL, Ayala de la Peña F. Ultrasound staging in breast cancer: A decision-making oriented approach to axillary metastatic burden prediction. Surg Oncol. 2020 Dec;35:114-119. PMID: 32871545

Muñoz-Langa J, Jimenez-Fonseca P, Carmona-Bayonas A, de Castro EM, Pérez-Segura P, Cánovas MS, Gomez D, Moran LO, de Tejada MBG, Seguí E, López GB, Adrián SG, Campos MC, Olmos VP, Portero BO, Moyano MS, Crespo JAS, Sánchez LT, Rebollo MA, Rivas PO, Altozano JP, Lescure ÁR, Muñoz-Martín A. Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology). Clin Transl Oncol. 2020 Aug 13. doi: 10.1007/s12094-020-02472-x. PMID: 32789772

Yamazaki T, Kirchmair A, Sato A, Buqué A, Rybstein M, Petroni G, Bloy N, Finotello F, Stafford L, Navarro Manzano E, Ayala de la Peña F, García-Martínez E, Formenti SC, Trajanoski Z, Galluzzi L. Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nat Immunol. 2020 Oct;21(10):1160-1171. doi: 10.1038/s41590-020-0751-0. Epub 2020 Aug 3. PMID: 32747819

Gomez D, Calderón C, Carmona-Bayonas A, Cacho Lavin D, Muñoz MM, Martinez Cabañez R, Jimenez-Fonseca P. Impact of adjuvant therapy toxicity on quality of life and emotional symptoms in patients with colon cancer: a latent class analysis. Clin Transl Oncol. 2020 Jul 16. doi: 10.1007/s12094-020-02454-z. PMID: 32676895.

Conteduca V, Wetterskog D, Scarpi E, Romanel A, Gurioli G, Jayaram A, Lolli C, Tandefelt DG, Schepisi G, Casadei C, Wingate A, Matteucci F, Paganelli G, Gonzalez-Billalabeitia E, Demichelis F, De Giorgi U, Attard G.Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer. Br J Cancer. 2020 Sep;123(6):982-987.PMID: 32669676

Castañon E, Sanchez-Arraez A, Alvarez-Manceñido F, Jimenez-Fonseca P, Carmona-Bayonas A. Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings. Eur J Cancer. 2020 Sep;136:159-168. doi: 10.1016/j.ejca.2020.06.003. Epub 2020 Jul 19. Erratum in: Eur J Cancer. 2020 Nov 5;: PMID: 32698098.

Solange Peters , Sarah Danson , Baktiar Hasan , Urania Dafni , Niels Reinmuth , Margarita Majem , Kurt G Tournoy , Michael T Mark , Miklos Pless , Manuel Cobo , Delvys Rodriguez-Abreu , Lionel Falchero , Teresa Moran , Ana Laura Ortega Granados , Isabelle Monnet , Katja Mohorcic , Bartomeu Massutí Sureda , Daniel Betticher , Ingel Demedts , Jose Antionio Macias , Sinead Cuffe , Andrea Luciani , Jose Garcia Sanchez , Alessandra Curioni-Fontecedro, Oliver Gautschi, Gillian Price, Linda Coate, Roger von Moos, Christoph Zielinski, Mariano Provencio, Jessica Menis, Barbara Ruepp, Alessia Pochesci, Heidi Roschitzki-Voser, Benjamin Besse, Manuela Rabaglio, Mary E R O'Brien, Rolf A Stahel. A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial. J Thorac Oncol 2020 Oct;15(10):1647-1656. PMID: 32565388

A Rodríguez-Lescure; F Ayala de la Peña; E Aranda; A Calvo; E Felip; P Garrido; R Vera. Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain. Clinical and Translational Oncology. 22, pp. 2253 - 2263. 12/06/2020. PMID: 32533318

Carmona-Bayonas A, Jimenez-Fonseca P, Castañón E. A Trial of Lopinavir-Ritonavir in Covid-19. N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5. PMID: 32369285

Cotes Sanchís A, Gallego J, Hernandez R, Arrazubi V, Custodio A, Cano JM, Aguado G, Macias I, Lopez C, López F, Visa L, Garrido M, Martínez Lago N, Fernández Montes A, Limón ML, Azkárate A, Pimentel P, Reguera P, Ramchandani A, Cacho JD, Martín Carnicero A, Granja M, Martín Richard M, Hernández Pérez C, Hurtado A, Serra O, Buxo E, Vidal Tocino R, Jimenez-Fonseca P, Carmona-Bayonas A. Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry. PLoS One. 2020 Jul 31;15(7):e0235848. doi: 10.1371/journal.pone.0235848. PMID: 32735623

Publicaciones en 2019

Carmona-Bayonas A, Jiménez-Fonseca P, Lamarca Á, Barriuso J, Castaño Á, Benavent M, Alonso V, Riesco-Martínez MDC, Alonso-Gordoa T, Custodio A, Sánchez Cánovas M, Hernando Cubero J, López C, Lacasta A, Fernández Montes A, Marazuela M, Crespo G, Escudero P, Diaz JÁ, Feliciangeli E, Gallego J, Llanos M, Segura Á, Vilardell F, Percovich JC, Grande E, Capdevila J, Valle JW, García-Carbonero R. Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study. J Clin Oncol. 2019 Aug 7:JCO1900980. doi: 10.1200/JCO.19.00980. PMID: 31390276

Conteduca V, Castro E, Wetterskog D, Scarpi E, Jayaram A, Romero-Laorden N, Olmos D, Gurioli G, Lolli C, Sáez MI, Puente J, Schepisi G, Salvi S, Wingate A, Medina A, Querol-Niñerola R, Marin-Aguilera M, Arranz JA, Fornarini G, Basso U, Mellado B, Gonzalez-Billalabeitia E, Attard G, De Giorgi U. Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer. Eur J Cancer. 2019 Jul;116:158-168. doi: 10.1016/j.ejca.2019.05.007. Epub 2019 Jun 11. PMID: 31200322

Luengo-Gil G, García-Martínez E, Chaves-Benito A, Conesa-Zamora P, Navarro-Manzano E, González-Billalabeitia E, García-Garre E, Martínez-Carrasco A, Vicente V, Ayala de la Peña F. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy. Cell Oncol (Dordr). 2019 May 21. doi: 10.1007/s13402-019-00450-2. PMID: 31115881

Carriles C, Jimenez-Fonseca P, Sánchez-Cánovas M, Pimentel P, Carmona-Bayonas A, García T, Carbajales-Álvarez M, Lozano-Blázquez A. Trifluridine/Tipiracil (TAS-102) for refractory metastatic colorectal cancer in clinical practice: a feasible alternative for patients with good performance status. Clin Transl Oncol. 2019 Jun 17. doi: 10.1007/s12094-019-02154-3. PMID: 31209792

Fernández Montes A, López López C, Argilés Martínez G, Páez López D, López Muñoz AM, García Paredes B, Gutiérrez Abad D, Castañón López C, Jiménez Fonseca P, Gallego Plazas J, López Doldán MC, Martínez de Castro E, Sánchez Cánovas M, Tobeña Puyal M, Llorente Ayala B, Juez Martel I, López Flores M, Carmona-Bayonas A. Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis. Oncologist. 2019 May 30. pii: theoncologist.2018-0824. doi: 10.1634/theoncologist.2018-0824. PMID: 31147489

Calderon C, Carmona-Bayonas A, Jara C, Beato C, Mediano M, Ramón Y Cajal T, Carmen Soriano M, Jiménez-Fonseca P. Emotional functioning to screen for psychological distress in breast and colorectal cancer patients prior to adjuvant treatment initiation. Eur J Cancer Care (Engl). 2019 May;28(3):e13005. doi: 10.1111/ecc.13005. Epub 2019 Feb 13.PMID: 30761638

Calderon C, Carmona-Bayonas A, Hernández R, Ghanem I, Castelo B, Martinez de Castro E, Ferreira E, Ciria L, Muñiz M, Jimenez-Fonseca P. Effects of pessimism, depression, fatigue, and pain on functional health-related quality of life in patients with resected non-advanced breast cancer. Breast. 2019 Apr;44:108-112. doi: 10.1016/j.breast.2019.01.012. Epub 2019 Feb 2. PMID: 30735899

Hernández R, Calderon C, Carmona-Bayonas A, Rodríguez Capote A, Jara C, Padilla Álvarez A, Gómez-Camacho MLN, Beato C, Castelo B, Majem M, Muñoz MDM, Ivars A, Mangas-Izquierdo M, Rogado-Revuelta J, Jimenez-Fonseca P. Differences in coping strategies among young adults and the elderly with cancer. Psychogeriatrics. 2019 Feb 5. doi: 10.1111/psyg.12420. PMID: 30723983

Calderon C, Carmona-Bayonas A, Hernandez R, Castelo B, Varma S, Donnay O, Gomez D, Jimenez-Fonseca P. Incidence of sleep problems and their mediating role on depression and anxious preoccupation in patients with resected, non-advanced cancer: data from NEOcoping study. Clin Transl Oncol. 2019 Aug;21(8):1104-1107. doi: 10.1007/s12094-018-02018-2. Epub 2019 Feb 2. PMID: 30712235

Jiménez-Fonseca P, Martín MN, Carmona-Bayonas A, Calvo A, Fernández-Mateos J, Redrado M, Capdevila J, Lago NM, Lacasta A, Muñarriz J, Segura Á, Fuster J, Barón F, Llanos M, Serrano R, Castillo A, Cruz Hernández JJ, Grande E. Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib. Oncotarget. 2018 Dec 11;9(97):36894-36905. doi: 10.18632/oncotarget.26380. eCollection 2018 Dec 11. PMID: 30651923

Lorenzo-Seva U, Calderon C, Ferrando PJ, Del Mar Muñoz M, Beato C, Ghanem I, Castelo B, Carmona-Bayonas A, Hernández R, Jiménez-Fonseca P. Psychometric properties and factorial analysis of invariance of the Satisfaction with Life Scale (SWLS) in cancer patients. Qual Life Res. 2019 May;28(5):1255-1264. doi: 10.1007/s11136-019-02106-y. Epub 2019 Jan 14. PMID: 30644028

Carmona-Bayonas A, Jiménez-Fonseca P. Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors. Clin Transl Oncol. 2019 Aug;21(8):1112-1114. doi: 10.1007/s12094-018-02020-8. Epub 2019 Jan 3. PMID: 30607791

Aparicio J, Sánchez-Muñoz A, Ochenduszko S, Gumà J, Fernández-Aramburo A, García Del Muro X, Quiroga V, Sastre J, Alonso-Gordoa T, Sagastibelza N, Maroto P, Gómez de Liaño A, Vázquez S, Diz P, Durán I, Domenech M, Pinto A, Hernández A, González-Billalabeitia E, Terrasa J. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group. J Urol. 2019 Jun 4:101097JU0000000000000366. doi: 10.1097/JU.0000000000000366. PMID: 31163007

Conteduca V, Jayaram A, Romero-Laorden N, Wetterskog D, Salvi S, Gurioli G, Scarpi E, Castro E, Marin-Aguilera M, Lolli C, Schepisi G, Maugeri A, Wingate A, Farolfi A, Casadio V, Medina A, Puente J, Vidal MJM, Morales-Barrera R, Villa-Guzmán JC, Hernando S, Rodriguez-Vida A, González-Del-Alba A, Mellado B, Gonzalez-Billalabeitia E, Olmos D, Attard G, De Giorgi U. Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2019 Mar;75(3):368-373. doi: 10.1016/j.eururo.2018.09.049. Epub 2018 Oct 26. PMID: 30773204

Castro E, Romero-Laorden N, Del Pozo A, Lozano R, Medina A, Puente J, Piulats JM, Lorente D, Saez MI, Morales-Barrera R, Gonzalez-Billalabeitia E, Cendón Y, García-Carbonero I, Borrega P, Mendez Vidal MJ, Montesa A, Nombela P, Fernández-Parra E, Gonzalez Del Alba A, Villa-Guzmán JC, Ibáñez K, Rodriguez-Vida A, Magraner-Pardo L, Perez-Valderrama B, Vallespín E, Gallardo E, Vazquez S, Pritchard CC, Lapunzina P, Olmos D. PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol. 2019 Feb 20;37(6):490-503. doi: 10.1200/JCO.18.00358. Epub 2019 Jan 9. PMID: 30625039

García-García T, Carmona-Bayonas A, Jimenez-Fonseca P, Jara C, Beato C, Castelo B, Mangas M, de Castro EM, Ramchandani A, Gomez D, Calderón C. Biopsychosocial and clinical characteristics in patients with resected breast and colon cancer at the beginning and end of adjuvant treatment. BMC Cancer. 2019 Nov 26;19(1):1143. doi: 10.1186/s12885-019-6358-x. PMID: 31771533

Ivars Rubio A, Yufera JC, de la Morena P, Fernández Sánchez A, Navarro Manzano E, García Garre E, García Martinez E, Marín Zafra G, Sánchez Cánovas M, García Torralba E, Ayala de la Peña F. Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables. Sci Rep. 2019 Nov 18;9(1):16979. doi: 10.1038/s41598-019-53606-3. PMID: 31740715

Flores-Funes D, Aguilar-Jiménez J, Martínez-Gálvez M, Ibáñez-Ibáñez MJ, Carrasco-González L, Gil-Izquierdo JI, Chaves-Benito MA, Ayala-De La Peña F, Nieto-Olivares A, Aguayo-Albasini JL. Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results. Surg Oncol. 2019 Sep;30:52-57. doi: 10.1016/j.suronc.2019.05.019. PMID: 31500785

López-Fernández T, Martín-García A, Roldán Rabadán I, Mitroi C, Mazón Ramos P, Díez-Villanueva P, Escobar Cervantes C, Alonso Martín C, Alonso Salinas GL, Arenas M, Arrarte Esteban VI, Ayala de La Peña F, Castro Fernández A, García Pardo H, García-Sanz R, González Porras JR, López de Sá E, Lozano T, Marco Vera P, Martínez Marín V, Mesa Rubio D, Montero Á, Oristrell G, Pérez de Prado A, Velasco Del Castillo S, Virizuela Echaburu JA, Zatarain-Nicolás E, Anguita Sánchez M, Tamargo Menéndez J; Expert reviewers.Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations. Rev Esp Cardiol (Engl Ed). 2019 Sep;72(9):749-759. doi: 10.1016/j.rec.2019.03.019. Epub 2019 Aug 9. PMID: 31405794

Calderón C, Jiménez-Fonseca P, Hernández R, Mar Muñoz MD, Mut M, Mangas-Izquierdo M, Vicente MÁ, Ramchandani A, Carmona-Bayonas A. Quality of life, coping, and psychological and physical symptoms after surgery for non-metastatic digestive tract cancer. Surg Oncol. 2019 Dec;31:26-32. doi: 10.1016/j.suronc.2019.08.009. Epub 2019 Aug 23. PMID: 31493647

Solis-Hernandez MP, Fernandez Del Valle A, Carmona-Bayonas A, Garcia-Carbonero R, Custodio A, Benavent M, Alonso Gordoa T, Nuñez-Valdovino B, Sanchez Canovas M, Matos I, Alonso V, Lopez C, Viudez A, Izquierdo M, Calvo-Temprano D, Grande E, Capdevila J, Jimenez-Fonseca P. Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study). Br J Cancer. 2019 Oct;121(7):537-544. doi: 10.1038/s41416-019-0558-7. PMID: 31477779

Carmona-Bayonas A, Jimenez-Fonseca P, Garrido M, Custodio A, Hernandez R, Lacalle A, Cano JM, Aguado G, Martínez de Castro E, Alvarez Manceñido F, Macias I, Visa L, Martín Richard M, Mangas M, Sánchez Cánovas M, Longo F, Iglesias Rey L, Martínez Lago N, Martín Carnicero A, Sánchez A, Azkárate A, Limón ML, Hernández Pérez C, Ramchandani A, Pimentel P, Cerdá P, Serrano R, Gil-Negrete A, Marín M, Hurtado A, Sánchez Bayona R, Gallego J. Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer. Thromb Haemost. 2019 Nov;119(11):1849-1859. doi: 10.1055/s-0039-1694012. PMID: 31461750

Publicaciones en 2018

Smith M, García-Martínez E, Pitter MR, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L.Trial Watch: Toll-like receptor agonists in cancer immunotherapy. Oncoimmunology. 2018 Oct 11;7(12):e1526250. doi: 10.1080/2162402X.2018.1526250. eCollection 2018. Review. PMID: 30524908

Fernández A, Salgado M, García A, Buxò E, Vera R, Adeva J, Jiménez-Fonseca P, Quintero G, Llorca C, Cañabate M, López LJ, Muñoz A, Ramírez P, González P, López C, Reboredo M, Gallardo E, Sanchez-Cánovas M, Gallego J, Guillén C, Ruiz-Miravet N, Navarro-Pérez V, De la Cámara J, Alés-Díaz I, Pazo-Cid RA, Carmona-Bayonas A. Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study. BMC Cancer. 2018 Nov 29;18(1):1185. doi: 10.1186/s12885-018-5101-3.PMID: 30497432

Carmona-Bayonas A, Jimenez-Fonseca P, de Castro EM, Mata E, Biosca M, Custodio A, Espinosa J, Vázquez EG, Henao F, Ayala de la Peña F.SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018). Clin Transl Oncol. 2018 Nov 23. doi: 10.1007/s12094-018-1983-4. [Epub ahead of print] PMID: 30470991

Ayala de la Peña F, Andrés R, Garcia-Sáenz JA, Manso L, Margelí M, Dalmau E, Pernas S, Prat A, Servitja S, Ciruelos E. SEOM clinical guidelines in early stage breast cancer (2018). Clin Transl Oncol. 2018 Nov 15. doi: 10.1007/s12094-018-1973-6. [Epub ahead of print] PMID: 30443868

González-Billalabeitia E, Conteduca V, Wetterskog D, Jayaram A, Attard G. Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test. Prostate Cancer Prostatic Dis. 2018 Nov 9. doi: 10.1038/s41391-018-0098-x. [Epub ahead of print] PMID: 30413805

Otero MJ, Vera R, González-Pérez C, Ayala de la Peña F, Peñuelas Á, Quer N. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients. Farm Hosp. 2018 Nov 1;42(6):261-268. doi: 10.7399/fh.11132. PMID: 30381047

Rosino A, Ballester I, Tudela J, González-Billalabeitia E. Chemotherapy in metastatic castration resistant prostate cancer. Arch Esp Urol. 2018 Sep;71(8):676-684. PMID: 30319127

Vera R, Otero MJ, Ayala de la Peña F, González-Pérez C, Peñuelas Á, Sepúlveda JM, Quer N, Doménech-Climent N, Virizuela JA, Beorlegui P, Gorgas MQ. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society

of Medical Oncology for the safe management of antineoplastic medication in cancer patients. Clin Transl Oncol. 2018 Oct 8. doi: 10.1007/s12094-018-1945-x. [Epub ahead of print] PMID: 30298467

Calderon C, Carmona-Bayonas A, Beato C, Ghanem I, Hernandez R, Majem M, Rosa Diaz A, Higuera O, Mut Lloret M, Jimenez-Fonseca P.Risk of malnutrition and emotional distress as factors affecting health-related quality of life in patients with resected cancer. Clin Transl Oncol. 2018 Oct 3. doi: 10.1007/s12094-018-1954-9. [Epub ahead of print] PMID: 30284234

Carmona-Bayonas A, Gordo F, Beato C, Castaño Pérez J, Jiménez-Fonseca P, Virizuela Echaburu J, Garnacho-Montero J. Complexity and uncertainty in the critical care of cancer patients in the era of immunotherapy and targeted therapies. Med Intensiva. 2018 Dec;42(9):570-571. doi: 10.1016/j.medin.2018.05.001. Epub 2018 Jun 11. PMID: 29903636

García-Martínez E, Smith M, Buqué A, Aranda F, de la Peña FA, Ivars A, Cánovas MS, Conesa MAV, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. Oncoimmunology. 2018 Feb 15;7(6):e1433982. doi: 10.1080/2162402X.2018.1433982. eCollection 2018. PMID: 29872569

Santaballa A, García Y, Herrero A, Laínez N, Fuentes J, De Juan A, Rodriguez Freixinós V, Aparicio J, Casado A, García-Martinez E. SEOM clinical guidelines in gestational trophoblastic disease (2017). Clin Transl Oncol. 2018 Jan;20(1):38-46. doi: 10.1007/s12094-017-1793-0. Epub 2017 Nov 17. PMID: 29149431

Luengo-Gil G, Gonzalez-Billalabeitia E, Perez-Henarejos SA, Navarro Manzano E, Chaves-Benito A, Garcia-Martinez E, Garcia-Garre E, Vicente V, Ayala de la Peña F.Angiogenic role of miR-20a in breast cancer. PLoS One. 2018 Apr 4;13(4):e0194638. doi: 10.1371/journal.pone.0194638. PMID: 29617404

Paumard-Hernández B, Calvete O, Inglada Pérez L, Tejero H, Al-Shahrour F, Pita G, Barroso A, Triviño JC, Urioste M, Valverde C, González Billalabeitia E, Quiroga V, Rodríguez Moreno JF, Fernández Aramburo A, López C, Maroto P, Sastre J, Juan Fita MJ, Duran I, Lorenzo-Lorenzo I, Iranzo P, García Del Muro X, Ros S, Zambrana F, Autran AM, Benítez J. Whole Exome Sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer. Int J Cancer. 2018 May 15. PMID: 29761480

Aparicio J, Sánchez-Muñoz A, Gumà J, Domenech M, Meana JA, García-Sánchez J, Bastús R, Gironés R, González-Billalabeitia E, Sagastibelza N, Ochenduszko S, Sánchez A, Terrasa J, Germà-Lluch JR, García Del Muro X; on behalf of the Spanish Germ Cell Cancer Group.A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study. Oncology. 2018;95(1):8-12. doi: 10.1159/000487438. PMID: 29587278

García Garre E, Luengo Gil G, Montoro García S, Gonzalez Billalabeitia E, Zafra Poves M, García Martinez E, Roldán Schilling V, Navarro Manzano E, Ivars Rubio A, Lip GYH, Ayala de la Peña F. Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis. Breast Cancer Res Treat. 2018 May;169(1):83-92. doi: 10.1007/s10549-017-4656-z. PMID: 29340882

Muñoz-Sánchez MM, Calderon C, Jimenez-Fonseca P, Soriano-Rodríguez MC, Jara C, García-García T, Beato C, Rogado J, Castelo B, Hernández R, Mangas-Izquierdo M, Carmona-Bayonas A.Prospective analysis of psychological differences between adult and elderly cancer patients during postoperative adjuvant chemotherapy. Clin Transl Oncol. 2018 Jun 4. doi: 10.1007/s12094-018-1901-9. PMID: 29869041

Calderón C, Jimenez-Fonseca P, Jara C, Hernández R, Martínez de Castro E, Varma S, Ghanem I, Carmona-Bayonas A. Comparison of Coping, Psychological Distress, and Level of Functioning in Patients With Gastric and Colorectal Cancer Before Adjuvant Chemotherapy. J Pain Symptom Manage. 2018 Jun 13. pii: S0885-3924(18)30255-0. doi: 10.1016/j.jpainsymman.2018.05.010. PMID: 29775693

Carmona-Bayonas A, Jiménez-Fonseca P, Echavarria I, Sánchez Cánovas M, Aguado G, Gallego J, Custodio A, Hernández R, Viudez A, Cano JM, Martínez de Castro E, Macías I, Martín Carnicero A, Garrido M, Mangas M, Álvarez Manceñido F, Visa L, Azkarate A, Ramchandani A, Fernández Montes A, Longo F, Sánchez A, Pimentel P, Limón ML, Arias D, Cacho Lavin D, Sánchez Bayona R, Cerdá P, García Alfonso P; AGAMENON Study Group. Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry. Eur J Surg Oncol. 2018 Mar 31. pii: S0748-7983(18)30988-0. doi: 10.1016/j.ejso.2018.03.019. PMID: 29685755

Owen GI, Pinto MP, Retamal IN, Fernádez MF, Cisternas B, Mondaca S, Sanchez C, Galindo H, Nervi B, Ibañez C, Acevedo F, Madrid J, Peña J, Bravo ML, Maturana MJ, Cordova-Delgado M, Romero D, de la Jara N, Torres J, Rodriguez-Fernandez M, Espinoza M, Balmaceda C, Freire M, Gárate-Calderón V, Crovari F, Jimenez-Fonseca P, Carmona-Bayonas A, Zwenger A, Armisen R, Corvalan AH, Garrido M. Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients. Medicine (Baltimore). 2018 Apr;97(16):e0419. doi: 10.1097/MD.0000000000010419. PMID: 29668600

Jimenez-Fonseca P, Calderón C, Hernández R, Ramón Y Cajal T, Mut M, Ramchandani A, Donnay O, Carmona-Bayonas A. Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy. Clin Transl Oncol. 2018 Apr 12. doi: 10.1007/s12094-018-1873-9. PMID: 29651672

Jimenez-Fonseca P, Calderon C, Carmona-Bayonas A, Muñoz MM, Hernández R, Mut Lloret M, Ghanem I, Beato C, Cacho Lavín D, Ivars Rubio A, Carrión R, Jara C. The relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables. Clin Transl Oncol. 2018 Apr 2. doi: 10.1007/s12094-018-1870-z. PMID: 29611043

Nuñez-Valdovinos B, Carmona-Bayonas A, Jimenez-Fonseca P, Capdevila J, Castaño-Pascual Á, Benavent M, Pi Barrio JJ, Teule A, Alonso V, Custodio A, Marazuela M, Segura Á, Beguiristain A, Llanos M, Martinez Del Prado MP, Diaz-Perez JA, Castellano D, Sevilla I, Lopez C, Alonso T, Garcia-Carbonero R. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE). Oncologist. 2018 Jan 12. pii: theoncologist.2017-0364. doi: 10.1634/theoncologist.2017-0364.PMID: 29330208

Carmona-Bayonas A, Jimenez-Fonseca P, Fernández-Somoano A, Álvarez-Manceñido F, Castañón E, Custodio A, de la Peña FA, Payo RM, Valiente LP. Top ten errors of statistical analysis in observational studies for cancer research. Clin Transl Oncol. 2018 Aug;20(8):954-965. doi: 10.1007/s12094-017-1817-9. PMID: 29218627

Jimenez-Fonseca P, Lorenzo-Seva U, Ferrando PJ, Carmona-Bayonas A, Beato C, García T, Muñoz MDM, Ramchandani A, Ghanem I, Rodríguez-Capote A, Jara C, Calderon C. The mediating role of spirituality (meaning, peace, faith) between psychological distress and mental adjustment in cancer patients. Support Care Cancer. 2018 May;26(5):1411-1418. doi: 10.1007/s00520-017-3969-0. PMID: 29143135

García Garre E, Luengo Gil G, Montoro García S, Gonzalez Billalabeitia E, Zafra Poves M, García Martinez E, Roldán Schilling V, Navarro Manzano E, Ivars Rubio A, Lip GYH, Ayala de la Peña F. Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis. Breast Cancer Res Treat. 2018 Jan 16. doi: 10.1007/s10549-017-4656-z. [Epub ahead of print] PMID: 29340882

Carmona-Bayonas A, Sánchez-Cánovas M, Plasencia JM, Custodio A, Martínez de Castro E, Virizuela JA, Ayala de la Peña F, Jiménez-Fonseca P.Key points to optimizing management and research on cancer-associated thrombosis. Clin Transl Oncol. 2018 Feb;20(2):119-126. doi: 10.1007/s12094-017-1692-4.PMID: 28593335

Chen M, Zhang J, Sampieri K, Clohessy JG, Mendez L, Gonzalez-Billalabeitia E, Liu XS, Lee YR, Fung J, Katon JM, Menon AV, Webster KA, Ng C, Palumbieri MD, Diolombi MS, Breitkopf SB, Teruya-Feldstein J, Signoretti S, Bronson RT, Asara JM, Castillo-Martin M, Cordon-Cardo C, Pandolfi PP. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer. Nat Genet. 2018 Feb;50(2):206-218. doi: 10.1038/s41588-017-0027-2. Epub 2018 Jan 15. PMID: 29335545

Carmona-Bayonas A, Gordo F, Beato C, Castaño Pérez J, Jiménez-Fonseca P, Virizuela Echaburu J, Garnacho-Montero J.Intensive care in cancer patients in the age of immunotherapy and molecular therapies: Commitment of the SEOM-SEMICYUC. Med Intensiva. 2018 Mar 5. pii: S0210-5691(18)30019-6. doi: 10.1016/j.medin.2018.01.008. PMID: 29519710

Visa L, Jiménez-Fonseca P, Martínez EA, Hernández R, Custodio A, Garrido M, Viudez A, Buxo E, Echavarria I, Cano JM, Macias I, Mangas M, de Castro EM, García T, Manceñido FÁ, Montes AF, Azkarate A, Longo F, Serrano AD, López C, Hurtado A, Cerdá P, Serrano R, Gil-Negrete A, Carnicero AM, Pimentel P, Ramchandani A, Carmona-Bayonas A; AGAMENON Study Group. Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis. J Geriatr Oncol. 2017 Dec 11. pii: S1879-4068(17)30247-3. doi: 10.1016/j.jgo.2017.11.008.PMID: 29242093

Publicaciones en 2017

Wennerberg E, Lhuillier C, Vanpouille-Box C, Pilones KA, García-Martínez E, Rudqvist NP, Formenti SC, Demaria S. Barriers to Radiation-Induced In Situ Tumor Vaccination. Front Immunol. 2017 Mar 13;8:229. doi: 10.3389/fimmu.2017.00229. PMID: 2834855

Miguel Martin; Ignacio Chacon; Antonio Antón; Arrate Plazaola; Elena García Martínez; Miguel Angel Seguí; Pedro Sanchez Rovira; Jose Palacios; Lourdes Calvo; Carmen Esteban; Enrique Espinosa; Agustí Barnadas; Norberto Batista; Angel Guerrero; Montserrat Muñoz; Estefania Romio; Cesar Rodriguez Martin; Rosalía Caballero; M Isabel Casas; Federico Rojo; Eva Carrasco; Silvia Antonin. Neoadjuvant therapy with weekly nab-Paclitaxel for luminal early breast cancer patients: Results from the Nabrax study (GEICAM/2011-02), a multicenter, non-randomized, phase IItrial, with a companion biomarker analysis. Oncologist. 2017 Nov;22(11):1301-1308. doi: 10.1634/theoncologist.2017-0052. Epub 2017 Jul 12. PMID: 28701571

Ana Santaballa; Yolanda García; Ana Herrero; Nuria Laínez; Jose Fuentes; Ana de Juan; Víctor Rodríguez Freixinos; Jorge Aparicio; Antonio Casado; Elena García Martínez. SEOM clinical guideline in gestational trophoblastic disease (2017). Clin Transl Oncol. 2017 Dec 13. doi: 10.1007/s12094-017-1809-9. [Epub ahead of print]. PMID: 29238915

Carmona-Bayonas A, Jimenez-Fonseca P, Fernández-Somoano A, Álvarez-Manceñido F, Castañón E, Custodio A, de la Peña FA, Payo RM, Valiente LP . Top ten errors of statistical analysis in observational studies for cancer research. Clin Transl Oncol. 2017 Dec 7. doi: 10.1007/s12094-017-1817-9. [Epub ahead of print] Review. PMID: 29218627

Carmona-Bayonas A, Jiménez-Fonseca P. CISNE or MASCC, which predictor is really the weakest in febrile neutropenia? Eur J Intern Med. 2017 Nov 17. pii: S0953-6205(17)30449-1. doi: 10.1016/j.ejim.2017.11.009. [Epub ahead of print] PMID: 29157884

Jimenez-Fonseca P, Lorenzo-Seva U, Ferrando PJ, Carmona-Bayonas A, Beato C, García T, Muñoz MDM, Ramchandani A, Ghanem I, Rodríguez-Capote A, Jara C, Calderon C. The mediating role of spirituality (meaning, peace, faith) between psychological distress and mental adjustment in cancer patients. Support Care Cancer. 2017 Nov 15. doi: 10.1007/s00520-017-3969-0. [Epub ahead of print] PMID: 29143135

Carmona-Bayonas A, Jiménez-Fonseca P.Prognostic Assessment of Febrile Neutropenia in the Emergency Department. Ann Emerg Med. 2017 Nov;70(5):753-754. doi: 10.1016/j.annemergmed.2017.07.015. PMID: 29056216

Jiménez Fonseca P, Carmona-Bayonas A, Hernández R, Custodio A, Cano JM, Lacalle A, Echavarria I, Macias I, Mangas M, Visa L, Buxo E, Álvarez Manceñido F, Viudez A, Pericay C, Azkarate A, Ramchandani A, López C, Martinez de Castro E, Fernández Montes A, Longo F, Sánchez Bayona R, Limón ML, Diaz-Serrano A, Martin Carnicero A, Arias D, Cerdà P, Rivera F, Vieitez JM, Sánchez Cánovas M, Garrido M, Gallego J. Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry. Br J Cancer. 2017 Sep 5;117(6):775-782. doi: 10.1038/bjc.2017.245. Epub 2017 Aug 1.

Jiménez-Fonseca P, Carmona-Bayonas A, Font C, Plasencia-Martínez J, Calvo-Temprano D, Otero R, Beato C, Biosca M, Sánchez M, Benegas M, Varona D, Faez L, Antonio M, de la Haba I, Madridano O, Solis MP, Ramchandani A, Castañón E, Marchena PJ, Martín M, de la Peña FA, Vicente V; EPIPHANY study investigators and the Asociación de Investigación de la Enfermedad Tromboembólica de la Región de Murcia. The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism. Clin Transl Oncol. 2017 Jul 10. doi: 10.1007/s12094-017-1713-3. PMID: 2869547

Carmona-Bayonas A, Jiménez-Fonseca P. Prognostic Assessment of Febrile Neutropenia in the Emergency Department. Ann Emerg Med. 2017 Nov;70(5):753-754. doi: 10.1016/j.annemergmed.2017.07.015. PMID: 29056216

Antonio M, Carmona-Bayonas A, Saldaña J, Navarro V, Tebé C, Salazar R, Borràs JM. Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study. Clin Colorectal Cancer. 2017 Sep 28. pii: S1533-0028(17)30071-3. doi: 10.1016/j.clcc.2017.09.003. PMID: 29054805.

Carmona-Bayonas A, Jiménez-Fonseca P, Custodio A, Grande E, Capdevila J, López C, Teule A, Garcia-Carbonero R; Spanish Neuroendocrine Tumor Group (GETNE). Optimizing Somatostatin Analog Use in Well or Moderately Differentiated Gastroenteropancreatic Neuroendocrine Tumors. Curr Oncol Rep. 2017 Sep 18;19(11):72. doi: 10.1007/s11912-017-0633-2. PMID: 28920153

Laquente B, Calsina-Berna A, Carmona-Bayonas A, Jiménez-Fonseca P, Peiró I, Carrato A. Supportive care in pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2017 Jun 13. doi: 10.1007/s12094-017-1682-6. PMID: 28612201

Lozano Martínez AJ, Moreno Cano R, Escobar Páramo S, Salguero Aguilar R, Gonzalez Billalabeitia E, García Fernández R, De La Fuente Muñoz I, Romero Borque A, Porras Martínez M, Lopez Soler F, Cardenas Cánovas E, Ortega Martín I. Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer. Clin Transl Oncol. 2017 Jul 17. doi: 10.1007/s12094-017-1699-x. PMID: 28718070

Irigoyen A, Gallego J, Guillén Ponce C, Vera R, Iranzo V, Ales I, Arévalo S, Pisa A, Martín M, Salud A, Falcó E, Sáenz A, Manzano Mozo JL, Pulido G, Martínez Galán J, Pazo-Cid R, Rivera F, García García T, Serra O, Fernández Parra EM, Hurtado A, Gómez Reina MJ, López Gomez LJ, Martínez Ortega E, Benavides M, Aranda E; Spanish Cooperative Group of Treatment of Digestive Tumors (TTD). Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group. Eur J Cancer. 2017 Apr;75:73-82. doi: 10.1016/j.ejca.2016.12.032. PMID: 28222309

Feliu J, Díez de Corcuera I, Manzano JL, Valladares-Ayerbes M, Alcaide J, García García T, Vera R, Sastre J. Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain. Clin Transl Oncol. 2017 Apr;19(4):498-507. doi: 10.1007/s12094-016-1556-3. PMID: 27718155

Tavera-Tapia A, Pérez-Cabornero L, Macías JA, Ceballos MI, Roncador G, de la Hoya M, Barroso A, Felipe-Ponce V, Serrano-Blanch R, Hinojo C, Miramar-Gallart MD, Urioste M, Caldés T, Santillan-Garzón S, Benitez J, Osorio A. Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene. Breast Cancer Res Treat. 2017 Feb;161(3):597-604. doi: 10.1007/s10549-016-4058-7. PMID: 27913932

De Castro J, González-Larriba JL, Vázquez S, Massutí B, Sanchez-Torres JM, Dómine M, Garrido P, Calles A, Artal A, Collado R, García R, Sereno M, Majem M, Macías JA, Juan O, Gómez-Codina J, Hernández B, Lázaro M, Ortega AL, Cobo M, Trigo JM, Carcereny E, Rolfo C, Macia S, Muñoz J, Diz P, Méndez M, Rosillo F, Paz-Ares L, Cardona JV, Isla D. Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy. Clin Transl Oncol. 2017 Feb;19(2):219-226. doi: 10.1007/s12094-016-1527-8. PMID: 27371031

Carmona-Bayonas A, Jiménez-Fonseca P, Font C, Fenoy F, Otero R, Beato C, Plasencia JM, Biosca M, Sánchez M, Benegas M, Calvo-Temprano D, Varona D, Faez L, de la Haba I, Antonio M, Madridano O, Solis MP, Ramchandani A, Castañón E, Marchena PJ, Martín M, Ayala de la Peña F, Vicente V. Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index. Br J Cancer. 2017 Apr 11;116(8):994-1001. doi: 10.1038/bjc.2017.48. PMID: 28267709

Plasencia-Martínez JM, Carmona-Bayonas A, Calvo-Temprano D, Jiménez-Fonseca P, Fenoy F, Benegas M, Sánchez M, Font C, Varona D, Martínez de la Haza D, Pueyo J, Biosca M, Antonio M, Beato C, Solís P, Fáez L, de Al Haba I, Hernández-Muñiz S, Madridano O, Martín M, Castañón E, Ramchandani A, Marchena P, Sánchez-Cánovas M, Vicente MÁ, Martínez MJ, Fernández-Plaza Á, Martínez-Encarnación L, Puerta A, Domínguez Á, Rodríguez D, Marín G, Otero R, Sánchez-Lasheras F, Vicente V. Prognostic value of computed tomography pulmonary angiography indices in patients with cancer-related pulmonary embolism: Data from a multicenter cohort study. Eur J Radiol. 2017 Feb;87:66-75. doi: 10.1016/j.ejrad.2016.12.010. PMID: 28065377

Font C, Carmona-Bayonas A, Beato C, Reig Ò, Sáez A, Jiménez-Fonseca P, Plasencia JM, Calvo-Temprano D, Sanchez M, Benegas M, Biosca M, Varona D, Vicente MA, Faez L, Solís MD, de la Haba I, Antonio M, Madridano O, Castañon E, Martinez MJ, Marchena P, Ramchandani A, Dominguez A, Puerta A, Martinez de la Haza D, Pueyo J, Hernandez S, Fernandez-Plaza A, Martinez-Encarnacion L, Martin M, Marin G, Ayala F, Vicente V, Otero R; Asociación para la Investigación de la Enfermedad Tromboembólica de la región de MurciaClinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study. Eur Respir J. 2017 Jan 4;49(1). pii: 1600282. doi: 10.1183/13993003.00282-2016. PMID: 28052954

Carmona-Bayonas A, Sánchez-Cánovas M, Plasencia JM, Custodio A, Martínez de Castro E, Virizuela JA, Ayala de la Peña F, Jiménez-Fonseca P.Key points to optimizing management and research on cancer-associated thrombosis. Clin Transl Oncol. 2017 Jun 7. doi: 10.1007/s12094-017-1692-4. PMID: 28593335

Calderon C, Ferrando PJ, Carmona-Bayonas A, Lorenzo-Seva U, Jara C, Beato C, García T, Ramchandani A, Castelo B, Muñoz MM, Garcia S, Higuera O, Mangas-Izquierdo M, Jimenez-Fonseca P.Validation of SDM-Q-Doc Questionnaire to measure shared decision-making physician's perspective in oncology practice. Clin Transl Oncol. 2017 May 11. doi: 10.1007/s12094-017-1671-9. PMID: 28497424

Antonio M, Saldaña J, Carmona-Bayonas A, Navarro V, Tebé C, Nadal M, Formiga F, Salazar R, Borràs JM.Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making? Oncologist. 2017 May 9. pii: theoncologist.2016-0462. doi: 10.1634/theoncologist.2016-0462. PMID: 28487465

Custodio A, Carmona-Bayonas A, Jiménez-Fonseca P, Sánchez ML, Viudez A, Hernández R, Cano JM, Echavarria I, Pericay C, Mangas M, Visa L, Buxo E, García T, Rodríguez Palomo A, Álvarez Manceñido F, Lacalle A, Macias I, Azkarate A, Ramchandani A, Fernández Montes A, López C, Longo F, Sánchez Bayona R, Limón ML, Díaz-Serrano A, Hurtado A, Madero R, Gómez C, Gallego J. Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab. Br J Cancer. 2017 Jun 6;116(12):1526-1535. doi: 10.1038/bjc.2017.122. PMID: 28463962

Carmona-Bayonas A, Jiménez-Fonseca P, Custodio A, Sánchez Cánovas M, Hernández R, Pericay C, Echavarria I, Lacalle A, Visa L, Rodríguez Palomo A, Mangas M, Cano JM, Buxo E, Álvarez-Manceñido F, García T, Lorenzo JE, Ferrer-Cardona M, Viudez A, Azkarate A, Ramchandani A, Arias D, Longo F, López C, Sánchez Bayona R, Limón ML, Díaz-Serrano A, Fernández Montes A, Sala P, Cerdá P, Rivera F, Gallego J; . Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry. Gastric Cancer. 2017 Apr 9. doi: 10.1007/s10120-017-0718-5. PMID: 28393278

Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela Echaburu J, Sánchez Cánovas M, Ayala de la Peña F. The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score. Clin Transl Oncol. 2017 Mar 13. doi: 10.1007/s12094-017-1644-z. PMID: 28289961

Jimenez-Fonseca P, Carmona-Bayonas A, Calderon C, Fontcuberta Boj J, Font C, Lecumberri R, Monreal M, Muñoz Martín AJ, Otero R, Rubio A, Ruiz-Artacho P, Suarez Fernández C, Colome E, Pérez Segura P. FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence. Clin Transl Oncol. 2017 Feb 27. doi: 10.1007/s12094-017-1632-3. PMID: 28243988

Gonzalez-Billalabeitia E, Castellano D, Sobrevilla N, Guma J, Hervas D, Luengo MI, Aparicio J, Sanchez-Muñoz A, Mellado B, Saenz A, Valverde C, Fernandez A, Margeli M, Duran I, Fernandez S, Sastre J, Ros S, Maroto P, Manneh R, Cerezuela P, Carmona-Bayonas A. Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients. J Natl Cancer Inst. 2017 Jan 25;109(4). pii: djw265. doi: 10.1093/jnci/djw265PMID: 28122896

Carmona-Bayonas A, Jiménez Fonseca P, Virizuela Echaburu J. Tapentadol for Cancer Pain Management: A Narrative Review. Pain Pract. 2017 Jan 13. doi: 10.1111/papr.12556. PMID: 28084045

Carmona-Bayonas A, Jiménez-Fonseca P, Vázquez Olmos C, Vega Villar J. Hyperreligiosity in malignant brain tumors: a case report and accompanying bibliographic review. Neurocase. 2017 Feb;23(1):88-95. doi: 10.1080/13554794.2016.1265985. PMID: 27938192

Crespo G, Jiménez-Fonseca P, Custodio A, López C, Carmona-Bayonas A, Alonso V, Navarro M, Aller J, Sevilla I, Grande E, Gajate P, Alonso-Gordoa T, Matos I, Capdevila J, Nieto B, Barriuso J. Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience. Future Oncol. 2017 Mar;13(7):615-624. doi: 10.2217/fon-2016-0434. PMID: 27802780

Gabaldó Barrios X, Sarabia Meseguer MD, Marín Vera M, Sánchez Bermúdez AI, Macías Cerrolaza JA, Sánchez Henarejos P, Zafra Poves M, García Hernández MR, Cuevas Tortosa E, Aliaga Baño Á, Castillo Guardiola V, Martínez Hernández P, Tovar Zapata I, Martínez Barba E, Ayala de la Peña F, Alonso Romero JL, Noguera Velasco JA, Ruiz Espejo F.Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. Fam Cancer. 2017 May 5. doi: 10.1007/s10689-017-9985-x. PMID: 28477318

Conteduca V, Wetterskog D, Sharabiani MTA, Grande E, Fernandez-Perez MP, Jayaram A, Salvi S, Castellano D, Romanel A, Lolli C, Casadio V, Gurioli G, Amadori D, Font A, Vazquez-Estevez S, González Del Alba A, Mellado B, Fernandez-Calvo O, Méndez-Vidal MJ, Climent MA, Duran I, Gallardo E, Rodriguez A, Santander C, Sáez MI, Puente J, Gasi Tandefelt D, Wingate A, Dearnaley D; PREMIERE Collaborators; Spanish Oncology Genitourinary Group, Demichelis F, De Giorgi U, Gonzalez-Billalabeitia E, Attard G.Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study. Ann Oncol. 2017 May 3. doi: 10.1093/annonc/mdx155. PMID: 28472366

González Del Alba A, Arranz JÁ, Puente J, Méndez-Vidal MJ, Gallardo E, Grande E, Pérez-Valderrama B, González-Billalabeitia E, Lázaro-Quintela M, Pinto Á, Lainez N, Piulats JM, Esteban E, Maroto Rey JP, García JA, Suárez C. Recent advances in genitourinary tumors: A review focused on biology and systemic treatment. Crit Rev Oncol Hematol. 2017 May;113:171-190. doi: 10.1016/j.critrevonc.2017.03.010. PMID: 28427506

Bellmunt J, Kerst JM, Vázquez F, Morales-Barrera R, Grande E, Medina A, González Graguera M, Rubio G, Anido U, Fernández Calvo O, González-Billalabeitia E, Van den Eertwegh A, Pujol E, Perez-Gracia JL, González Larriba JL, Collado R, Los M, Maciá S, De Wit R; SOGUG and DUOS.A randomized Phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN). Ann Oncol. 2017 Apr 13. doi: 10.1093/annonc/mdx186. PMID: 28419193

Vila IK, Yao Y, Kim G, Xia W, Kim H, Kim SJ, Park MK, Hwang JP, González-Billalabeitia E, Hung MC, Song SJ, Song MS. A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy. Cancer Cell. 2017 Feb 13;31(2):208-224. doi: 10.1016/j.ccell.2017.01.003. PMID: 28162974

Perez-Gracia JL, Sanmamed MF, Bosch A, Patiño-Garcia A, Schalper KA, Segura V, Bellmunt J, Tabernero J, Sweeney CJ, Choueiri TK, Martín M, Fusco JP, Rodriguez-Ruiz ME, Calvo A, Prior C, Paz-Ares L, Pio R, Gonzalez-Billalabeitia E, Gonzalez Hernandez A, Páez D, Piulats JM, Gurpide A, Andueza M, de Velasco G, Pazo R, Grande E, Nicolas P, Abad-Santos F, Garcia-Donas J, Castellano D, Pajares MJ, Suarez C, Colomer R, Montuenga LM, Melero I.Strategies to design clinical studies to identify predictive biomarkers in cancer research. Cancer Treat Rev. 2017 Feb;53:79-97. doi: 10.1016/j.ctrv.2016.12.005. PMID: 28088073

Publicaciones en 2016

González-Martín A, Alba E, Ciruelos E, Cortés J, Llombart A, Lluch A, Andrés R, Álvarez I, Aramendía JM, de la Peña FA, Barnadas A, Batista N, Calvo L, Galve E, García-Palomo A, García-Sáenz JÁ, de la Haba J, López R, López-Vivanco G, Martínez-Jáñez N, de Dueñas EM, Plazaola A, Rodríguez-Lescure Á, Ruiz M, Sánchez- Rovira P, Santaballa A, Seguí MÁ, Tusquets I, Zamora P, Martín M. Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile. Curr Cancer Drug Targets. 2016; 16 (6):557-570.

Virizuela JA, Carratalà J, Aguado JM, Vicente D, Salavert M, Ruiz M, Ruiz I, Marco F, Lizasoain M, Jiménez-Fonseca P, Gudiol C, Cassinello J, Carmona-Bayonas A, Aguilar M, Cruz JJ. Management of infection and febrile neutropenia in patients with solid cancer. Clin Transl Oncol. 2016; 18 (6): 557-570.

Fonseca PJ, Carmona-Bayonas A, García IM, Marcos R, Castañón E, Antonio M, Font C, Biosca M, Blasco A, Lozano R, Ramchandani A, Beato C, de Castro EM, Espinosa J, Martínez-García J, Ghanem I, Cubero JH, Manrique IA, Navalón FG, Sevillano E, Manzano A, Virizuela J, Garrido M, Mondéjar R, Arcusa MÁ, Bonilla Y, Pérez Q, Gallardo E, Del Carmen Soriano M, Cardona M, Lasheras FS, Cruz JJ, Ayala F. A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia. Br J Cancer. 2016; 114 (11): 1191-8.

Carmona-Bayonas A, Jiménez-Fonseca P, Castañón E, Ramchandani-Vaswani A, Sánchez-Bayona R, Custodio A, Calvo-Temprano D, Virizuela JA. Chronic opioid therapy in long-term cancer survivors. Clin Transl Oncol. 2016 Jul 21.

Luengo-Gil G, Calvo MI, Martín-Villar E, Águila S, Bohdan N, Antón AI, Espín S, Ayala de la Peña F, Vicente V, Corral J, Quintanilla M, Martínez-Martínez I. Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase. Sci Rep. 2016; 6: 27544.

Carmona-Bayonas A, Font C, Jiménez-Fonseca P, Fenoy F, Otero R, Beato C, Plasencia J, Biosca M, Sánchez M, Benegas M, Calvo-Temprano D, Varona D, Faez L, Vicente MA, de la Haba I, Antonio M, Madridano O, Ramchandani A, Castañón E, Marchena PJ, Martínez MJ, Martín M, Marín G, Ayala de la Peña F, Vicente V; On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism. Asociación de Investigación de la Enfermedad Tromboembólica de la Región de Murcia. Thromb Res. 2016; 143: 76-85.

Aparicio J, Terrasa J, Durán I, Germà-Lluch JR, Gironés R, González-Billalabeitia E, Gumà J, Maroto P, Pinto A, García-Del-Muro X. SEOM clinical guidelines for the management of germ cell testicular cancer (2016). Clin Transl Oncol. 2016 Dec;18(12):1187-1196.

Carmona-Bayonas A, Jiménez-Fonseca P, Lorenzo ML, Ramchandani A, Martínez EA, Custodio A, Garrido M, Echavarría I, Cano JM, Barreto JE, García TG, Manceñido FÁ, Lacalle A, Cardona MF, Mangas M, Visa L, Buxó E, Azkarate A, Díaz-Serrano A, Montes AF, Rivera F. On the Effect of Triplet or Doublet Chemotherapy in Advanced Gastric Cancer: Results From a NaMonal Cancer Registry. J Natl Compr Canc Netw. 2016 Nov; 14(11):1379-1388.

Plasencia-Martínez JM, Carmona-Bayonas A, Calvo-Temprano D, Jiménez-Fonseca P. PrognosMc value of computed tomography in acute pulmonary thromboembolism. Radiologia. 2016 Sep-Oct;58(5):391-403.

Fonseca PJ, Carmona-Bayonas A, García IM, Marcos R, Castañón E, Antonio M, Font C, Biosca M, Blasco A, Lozano R, Ramchandani A, Beato C, de Castro EM, Espinosa J, Martínez-García J, Ghanem I, Cubero JH, Manrique IA, Navalón FG, Sevillano E, Manzano A, Virizuela J, Garrido M, Mondéjar R, Arcusa MÁ, Bonilla Y, Pérez Q, Gallardo E, Del Carmen Soriano M, Cardona M, Lasheras FS, Cruz JJ, Ayala F. A nomogram for predicMng complicaMons in paMents with solid tumours and seemingly stable febrile neutropenia. Br J Cancer. 2016 May 24;114(11):1191-8.

Virizuela JA, Carratalà J, Aguado JM, Vicente D, Salavert M, Ruiz M, Ruiz I, Marco F, Lizasoain M, Jiménez-Fonseca P, Gudiol C, Cassinello J, Carmona-Bayonas A, Aguilar M, Cruz JJ. Management of infecMon and febrile neutropenia in paMents with solid cancer. Clin Transl Oncol. 2016 Jun;18(6):557-70.

E. Garcia-Garre, G. Luengo-Gil, P. de la Morena, F. Ayala de la Peña. Microvesículas en cáncer de mama. Rev Senol Patol Mamar 2016; 29(3):125-131.

González A, Lluch A, Aba E, Albanell J, Antón A, Álvarez I, Ayala F, Barnadas A, Calvo L, Ciruelos E, Cortés J, de la Haba J, López-Vega JM, Martínez E, Muñoz M, Peláez I, Redondo A, Rodríguez Á, Rodríguez CA, Ruíz A, Llombart A. A definiMon for aggressive disease in paMents with HER-2 negaMve metastaMc breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM). Clin Transl Oncol. 2016 Nov 16.

Jiménez-Fonseca P, Carmona-Bayonas A, Sánchez Lorenzo ML, Plazas JG, Custodio A, Hernández R, Garrido M, García T, Echavarría I, Cano JM, Rodríguez Palomo A, Mangas M, Macías Declara I, Ramchandani A, Visa L, Viudez A, Buxó E, Díaz-Serrano A, López C, Azkarate A, Longo F, Castañón E, Sánchez Bayona R, Pimentel P, Limón ML, Cerdá P, Álvarez Llosa R, Serrano R, Lobera MP, Alsina M, Hurtado Nuño A, Gómez-Martín C. PrognosMc significance of performing universal HER2 tesMng in cases of advanced gastric cancer. Gastric Cancer. 2016 Sep 6.

Carmona-Bayonas A, Jiménez-Fonseca P, Vázquez Olmos C, Vega Villar J. Hyperreligiosity in malignant brain tumors: a case report and accompanying bibliographic review. Neurocase. 2016 Dec 12:1-8.

Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela J, Antonio M, Font C, Biosca M, Ramchandani A, MarMnez-Garcia J, Hernando J, Espinosa J, de Castro EM, Ghanem I, Beato C, Blasco A, Garrido M, Mondéjar R, Arcusa MÁ, Aragón I, Manzano A, Sevillano E, Castañón E, Ayala F. Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infecMons and tumors. Clin Transl Oncol. 2016 Aug 15.

Trillsch F, Mahner S, Hilpert F, Davies L, García-Martínez E, Kristensen G, Savarese A, Vuylsteke P, Los M, Zagouri F, Gladieff L, Sehouli J, Khoon Lee C, Gebski V, Pujade-Lauraine E.Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial. Ann Oncol. 2016 Sep;27(9):1733-9

Publicaciones en 2015

Luengo-Gil G, González-Billalabeitia E, Chaves-Benito A, García Martínez E, García Garre E, Vicente V, Ayala de la Peña F.Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis. Breast Cancer Res Treat. 2015;151 (3): 577-87.

de la Morena Barrio P, Conesa MÁ, González-Billalabeitia E, Urrego E, García-Garre E, García-Martínez E, Poves MZ, Vicente V, de la Peña FA. Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes.J Natl Compr Canc Netw. 2015; 13 (4): 417-23.

Font C, Carmona-Bayonas A, Plasencia JM, Calvo-Temprano D, Sánchez M, Jiménez- Fonseca P, Beato C, Biosca M, Vicente V, Otero R; en representación de los Investigadores del Proyecto EPIPHANY.[Pulmonary embolism in patients with cancer: foundations of the EPIPHANY study]. Med Clin (Barc). 2015;144 Suppl 1:31-7. Urrego EG, Carmona-Bayonas A, González-Billalabeitia E, Ayala de la Peña F.Should anticoagulation therapy be withheld in patients with active cancer after 6 months of low-molecular weight heparin? J Clin Oncol. 2015; 33 (15):1713

Carmona-Bayonas A, Jiménez-Fonseca P, VirizuelaEchaburu J, Antonio M, Font C, Biosca M, Ramchandani A, Martínez J, Hernando Cubero J, Espinosa J, Martínez de Castro E, Ghanem I, Beato C, Blasco A, Garrido M, Bonilla Y, Mondéjar R, ArcusaLanza MÁ, Aragón Manrique I, Manzano A, Sevillano E, Castañón E, Cardona M, Gallardo Martín E, Pérez Armillas Q, Sánchez Lasheras F, Ayala de la Peña F.Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol 2015; 33(5): 465-71.

Garcia-Carbonero R, Garcia-Figueiras R, Carmona-Bayonas A, Sevilla I, Teule A, Quindos M, Grande E, Capdevila J, Aller J, Arbizu J, Jimenez-Fonseca P; Spanish Cooperative Group of NeuroendocrineTumors (GETNE).Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development.Cancer Metastasis Rev. 2015; 34 (4): 823-42.

Jiménez-Fonseca P, Carmona-Bayonas A, Martín-Pérez E, Crespo G, Serrano R, Llanos M, Villabona C, García-Carbonero R, Aller J, Capdevila J, Grande E; Spanish Neuroendocrine Tumor Group. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors.Cancer Metastasis Rev. 2015; 34 (3): 381-400.

Carmona-Bayonas A, Fonseca PJ, Font C, Martínez-García J, Torrella F, Urrego E, Castaño P, Navarrete A, Antonio-Rebolla M, Gómez JG, Vicente V, Ayala F. Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution. J Community Support Oncol. 2014; 12 (9): 312-20.

Suárez C, Puente J, Gallardo E, Méndez-Vidal MJ, Climent MA, León L, Olmos D, García del Muro X, González-Billalabeitia E, Grande E, Bellmunt J, Mellado B, Maroto P, González del Alba A. New advances in genitourinary cancer: evidence gathered in 2014.Cancer Metastasis Rev. 2015; 34 (3): 443-64. Luengo-Gil G, González-Billalabeitia E, Chaves-Benito A, García Martínez E, García Garre E, Vicente V, Ayala de la Peña F. Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis.Breast Cancer Res Treat. 2015; 151 (3): 577-87.

Área Asistencial

Formación y docencia

Investigación

Área pacientes

Enlaces y Noticias de Interés

Contacto